GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes
The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.
VUMC sees continued gains in research funding and reputation
Vanderbilt University School of Medicine continues to make impressive strides in research funding, rankings and faculty accomplishments, Dean Jeff Balser, MD, PhD, said Friday during the spring faculty meeting.